The global diagnostic contract manufacturing market is projected to reach USD 44.9 Billion by 2028 from USD 26.0 Billion in 2023, at a CAGR of 11.5% during the forecast period. The growth of this market is majorly driven by the growth in the adoption of robotics and automation in manufacturing processes. However, the increasing adoption of refurbished diagnostic imaging systems challenges the growth of the diagnostic contract manufacturing market. “The diagnostic imaging devices segment accounted for the highest growth rate in the diagnostic contract manufacturing market, by device, during the forecast period.” Based on the type segment, the diagnostic contract manufacturing market is segmented into In vitro diagnostic devices, diagnostic imaging devices, and other devices. Diagnostic imaging devices include CT, X-ray, MRI, Ultrasound, and other imaging devices. Due to rapid economic growth, the adoption of these devices is expected to increase in developing countries in the coming years. “Orthopedics application segment accounted for the highest CAGR during the forecast period among diagnostic imaging devices application.” Based on application, the diagnostic imaging devices market is segmented into cardiology, neurology, orthopedics, oncology, and others. In 2022, cardiology dominated the market, and orthopedics observed the highest growth rate. Factors supporting the growth of orthopedics applications are the rising geriatric population and the growing prevalence of orthopedic diseases and disorders. “The Asia Pacific segment accounted for the highest growth rate in the diagnostic contract manufacturing systems market, by region, during the forecast period.” Based on the region, the global diagnostic contract manufacturing market is categorized into North America, Europe, Asia Pacific, and Rest of the World. Asia Pacific is expected to witness a high growth rate during the forecast period. Low labor costs and rapidly changing healthcare infrastructure hold massive potential for the Asia Pacific diagnostic contract manufacturing market. Breakdown of supply-side primary interviews by company type, designation, and region: • By Company Type: Tier 1- 55%, Tier 2- 40%, and Tier 3- 5% • By Designation: C-level - 37%, Director-level - 48%, and Others-15% • By Region: North America- 56%, Europe -17%, Asia- Pacific -20%, and Rest of the World -7% Prominent companies include Jabil Inc. (US), Flex Ltd. (Singapore), Plexus Corp. (US), Sanmina Corporation (US), TE Connectivity Ltd. (Switzerland), Celestica Inc. (Canada), Integer Holdings Corporation (US), Nipro Corporation (Japan), Thermo Fisher Scientific (US), West Pharmaceutical Services Inc. (US), Benchmark Electronics Inc. (US), Kimball Electronics Inc. (US), KMS Systems (US), Savyon Diagnostics (Israel), Nova Biomedical (US), Cenogenics Corporation (US), Cone Bioproducts (US), Avioq, Inc. (US), Philips-Medisize Corporation (US), Invetech (Australia), Meridian Bioscience, Inc. (US), Nolato AB (Sweden), Fujirebio (Japan), Sekisui (US), Prestige Diagnostics (UK), and Biokit (Spain). Research Coverage This research report categorizes the diagnostic contract manufacturing market by device (In Vitro Diagnostic Devices, Diagnostic Imaging Devices, Other Devices), services (Device Development and Manufacturing Services, Quality Management Services, Packaging and Assembly Services, and Other Services), end-user (In Vitro Diagnostic Devices (Infectious Diseases, Oncology, Cardiology, Others), Diagnostic Imaging Devices (Cardiology, Oncology, Orthopedics, Neurology, Others), Other Devices (Gastroenterology, Gynecology, Others), and region (North America, Europe, Asia Pacific, and Rest of the World). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the diagnostic contract manufacturing market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, services; key strategies; Contracts, partnerships, and agreements. New product & service launches, mergers and acquisitions, and recent developments associated with the diagnostic contract manufacturing market. Competitive analysis of upcoming startups in the diagnostic contract manufacturing market ecosystem is covered in this report. Key Benefits of Buying the Report: The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall diagnostic contract manufacturing market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities. The report provides insights on the following pointers: • Analysis of key drivers (early diagnosis and widening scope of clinical applications, adoption of robotics and automation in manufacturing processes, growing outsourcing activity by IVD manufacturers, and high cost of in-house IVD manufacturing), restraints (IP protection concerns and possibility of theft), opportunities (growth opportunities in emerging economies), and challenges (Increasing adoption of refurbished diagnostic imaging systems, lack of constant innovation to balance technological capabilities against costs, and shortage of skilled labor). • Market Development: Comprehensive information about lucrative markets – the report analyses the diagnostic contract manufacturing market across varied regions. • Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the diagnostic contract manufacturing market • Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Jabil Inc. (US), Flex Ltd. (Singapore), Plexus Corp. (US), Sanmina Corporation (US), TE Connectivity Ltd. (Switzerland), Celestica Inc. (Canada), among others in the diagnostic contract manufacturing market strategies.

1 INTRODUCTION 30 1.1 STUDY OBJECTIVES 30 1.2 MARKET DEFINITION 30 1.3 STUDY SCOPE 32 1.3.1 YEARS CONSIDERED 33 1.4 CURRENCY CONSIDERED 33 1.5 STAKEHOLDERS 33 2 RESEARCH METHODOLOGY 34 2.1 RESEARCH DATA 34 2.1.1 SECONDARY DATA 35 2.1.1.1 Key data from secondary sources 36 2.1.2 PRIMARY DATA 37 2.1.3 KEY INDUSTRY INSIGHTS 38 2.1.3.1 Key data from primary sources 38 2.1.3.2 Breakdown of primary interviews 39 2.2 MARKET SIZE ESTIMATION 39 2.2.1 BOTTOM-UP APPROACH 39 2.2.1.1 Approach 1: Company revenue estimation approach 40 2.2.1.2 Approach 2: Presentations of companies and primary interviews 40 2.2.1.3 Approach 3: COGS approach 40 2.2.1.4 Approach 4: Parent market approach (in-house vs. outsourcing market) 41 2.2.1.5 Growth forecast 42 2.2.1.6 CAGR projections 42 2.2.2 TOP-DOWN APPROACH 42 2.3 DATA TRIANGULATION 44 2.4 STUDY ASSUMPTIONS 45 2.5 RESEARCH LIMITATIONS AND RISK ASSESSMENT 45 3 EXECUTIVE SUMMARY 47 4 PREMIUM INSIGHTS 50 4.1 DIAGNOSTIC CONTRACT MANUFACTURING MARKET OVERVIEW 50 4.2 DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION (2023-2028) 51 4.3 ASIA PACIFIC: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE AND COUNTRY (2022) 52 4.4 DIAGNOSTIC CONTRACT MANUFACTURING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 53 5 MARKET OVERVIEW 54 5.1 INTRODUCTION 54 5.2 MARKET DYNAMICS 54 5.2.1 DRIVERS 55 5.2.1.1 Increasing demand for early diagnosis and widening scope of clinical applications 55 5.2.1.2 Adoption of robotics and automation in manufacturing processes 55 5.2.1.3 Growing outsourcing activity by IVD manufacturers 56 5.2.1.4 High cost of in-house IVD manufacturing 56 5.2.2 RESTRAINTS 57 5.2.2.1 IP protection concerns and possibility of IP theft 57 5.2.3 OPPORTUNITIES 57 5.2.3.1 Growth opportunities in emerging economies 57 5.2.4 CHALLENGES 57 5.2.4.1 Increasing adoption of refurbished diagnostic imaging systems 57 5.2.4.2 Lack of constant innovation to balance technological capabilities against costs 58 5.2.4.3 Shortage of skilled labor 58 5.3 SUPPLY CHAIN ANALYSIS 58 5.4 PORTER’S FIVE FORCES ANALYSIS 59 5.4.1 THREAT OF NEW ENTRANTS 59 5.4.2 THREAT OF SUBSTITUTES 60 5.4.3 BARGAINING POWER OF SUPPLIERS 60 5.4.4 BARGAINING POWER OF BUYERS 60 5.4.5 INTENSITY OF COMPETITIVE RIVALRY 61 5.5 ECOSYSTEM ANALYSIS 61 5.5.1 ROLE IN ECOSYSTEM 62 5.6 REGULATORY ANALYSIS 63 5.6.1 NORTH AMERICA 64 5.6.1.1 US 64 5.6.1.2 Canada 64 5.6.2 EUROPE 65 5.6.3 ASIA PACIFIC 65 5.6.3.1 Japan 65 5.6.3.2 China 66 5.6.3.3 India 68 5.7 KEY CONFERENCES AND EVENTS IN 2022-2023 68 5.8 TECHNOLOGY ANALYSIS 70 6 DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE 71 6.1 INTRODUCTION 72 6.2 IN VITRO DIAGNOSTIC DEVICES 72 6.2.1 IVD CONSUMABLES 73 6.2.1.1 Consumables segment to dominate IVD contract manufacturing market 73 6.2.2 IVD EQUIPMENT 74 6.2.2.1 Automation, advancements, and emphasis on efficient diagnostics to drive growth 74 6.3 DIAGNOSTIC IMAGING DEVICES 75 6.3.1 CT 76 6.3.1.1 Rising adoption of CT scanners for detection of tumors to support growth 76 6.3.2 ULTRASOUND 77 6.3.2.1 Minimally invasive nature of ultrasound to boost demand 77 6.3.3 X-RAY 78 6.3.3.1 Low cost of X-ray imaging compared to other modalities to drive growth 78 6.3.4 MRI 79 6.3.4.1 Innovation and advancement in MRI applications to drive demand 79 6.3.5 OTHER DIAGNOSTIC IMAGING DEVICES 80 6.4 OTHER DEVICES 81 7 DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE 83 7.1 INTRODUCTION 84 7.2 DEVICE DEVELOPMENT AND MANUFACTURING SERVICES 84 7.2.1 DEVICE MANUFACTURING SERVICES TO WITNESS HIGH GROWTH DURING FORECAST PERIOD 84 7.3 QUALITY MANAGEMENT SERVICES 85 7.3.1 STRINGENT REGULATIONS AND INCREASING PRODUCT SAFETY CONCERNS TO DRIVE DEMAND FOR QUALITY MANAGEMENT SERVICES 85 7.4 PACKAGING AND ASSEMBLY SERVICES 86 7.4.1 INCREASING PRODUCT SAFETY CONCERNS FOR MEDICAL DEVICES TO SUPPORT GROWTH 86 7.5 OTHER SERVICES 87 8 DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY APPLICATION 88 8.1 INTRODUCTION 89 8.2 IN VITRO DIAGNOSTIC DEVICE APPLICATIONS 89 8.2.1 INFECTIOUS DISEASES 89 8.2.1.1 Increasing incidence of infectious diseases to drive adoption of IVD devices 89 8.2.2 DIABETES 90 8.2.2.1 Rising prevalence of diabetes to drive adoption of glucose monitoring devices 90 8.2.3 ONCOLOGY 91 8.2.3.1 Rising initiatives for early detection of cancer to drive growth 91 8.2.4 CARDIOLOGY 92 8.2.4.1 Increasing use of immunoassays in detection of CVD to drive growth 92 8.2.5 OTHER APPLICATIONS (IVD DEVICES) 92 8.3 DIAGNOSTIC IMAGING DEVICE APPLICATIONS 93 8.3.1 CARDIOLOGY 94 8.3.1.1 High prevalence of CVD to drive growth 94 8.3.2 ONCOLOGY 94 8.3.2.1 Wide adoption of nuclear imaging systems to distinguish between benign and malignant tumors to drive growth 94 8.3.3 ORTHOPEDICS 95 8.3.3.1 Effective diagnosis and prognosis of musculoskeletal disorders by imaging devices to drive growth 95 8.3.4 NEUROLOGY 96 8.3.4.1 Innovations in 3D MRI technology to drive growth 96 8.3.5 OTHER APPLICATIONS (DIAGNOSTIC IMAGING DEVICES) 96 8.4 OTHER DEVICE APPLICATIONS 97 8.4.1 GASTROENTEROLOGY 98 8.4.1.1 Surging demand for early diagnosis to propel growth 98 8.4.2 GYNECOLOGY 99 8.4.2.1 Rising cases of cancer among women to drive growth 99 8.4.3 OTHER APPLICATIONS (OTHER DEVICES) 99 9 DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION 101 9.1 INTRODUCTION 102 9.2 ASIA PACIFIC 102 9.2.1 ASIA PACIFIC: IMPACT OF ECONOMIC RECESSION 102 9.2.2 CHINA 107 9.2.2.1 Low labor costs and rapidly changing healthcare infrastructure to drive growth 107 9.2.3 JAPAN 110 9.2.3.1 Need for advanced medical diagnostic tools to fuel growth 110 9.2.4 INDIA 113 9.2.4.1 Rising contract manufacturing capabilities to support growth 113 9.2.5 REST OF ASIA PACIFIC 116 9.3 NORTH AMERICA 119 9.3.1 NORTH AMERICA: IMPACT OF ECONOMIC RECESSION 119 9.3.2 US 124 9.3.2.1 Rising in-house manufacturing costs to drive shift toward contract manufacturing 124 9.3.3 CANADA 127 9.3.3.1 Strong presence of key manufacturing companies to augment market 127 9.4 EUROPE 131 9.4.1 EUROPE: IMPACT OF ECONOMIC RECESSION 131 9.4.2 GERMANY 135 9.4.2.1 Germany to hold largest market share in Europe 135 9.4.3 FRANCE 139 9.4.3.1 Strong focus on research and innovation of diagnostic devices to drive growth 139 9.4.4 UK 142 9.4.4.1 Increasing accessibility of IVD devices to drive growth 142 9.4.5 ITALY 145 9.4.5.1 Lack of supporting infrastructure to restrain growth 145 9.4.6 SPAIN 148 9.4.6.1 Increasing demand for diagnostic equipment to boost demand for contract manufacturing 148 9.4.7 REST OF EUROPE 151 9.5 REST OF THE WORLD 154 9.5.1 LATIN AMERICA: IMPACT OF ECONOMIC RECESSION 155 9.5.2 MIDDLE EAST & AFRICA: IMPACT OF ECONOMIC RECESSION 155 10 COMPETITIVE LANDSCAPE 159 10.1 OVERVIEW 159 10.2 STRATEGIES OF KEY PLAYERS/RIGHT TO WIN 159 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY DIAGNOSTIC CONTRACT MANUFACTURERS 159 10.3 REVENUE ANALYSIS 160 10.4 MARKET SHARE ANALYSIS 161 10.5 COMPANY EVALUATION MATRIX 163 10.5.1 STARS 163 10.5.2 EMERGING LEADERS 163 10.5.3 PERVASIVE PLAYERS 163 10.5.4 PARTICIPANTS 163 10.6 FOOTPRINT ANALYSIS OF COMPANIES 165 10.7 COMPETITIVE BENCHMARKING 168 10.8 COMPETITIVE SCENARIO 169 10.8.1 PRODUCT/SERVICE LAUNCHES AND APPROVALS 169 10.8.2 DEALS 170 10.8.3 OTHER DEVELOPMENTS 171 11 COMPANY PROFILES 172 11.1 KEY PLAYERS 172 11.1.1 JABIL INC 172 11.1.2 FLEX LTD 176 11.1.3 PLEXUS CORP 178 11.1.4 SANMINA CORPORATION 181 11.1.5 TE CONNECTIVITY LTD 185 11.1.6 CELESTICA INC 188 11.1.7 INTEGER HOLDINGS CORPORATION 190 11.1.8 NIPRO CORPORATION 192 11.1.9 THERMO FISHER SCIENTIFIC 195 11.1.10 WEST PHARMACEUTICAL SERVICES, INC 198 11.1.11 BENCHMARK ELECTRONICS INC 200 11.1.12 KIMBALL ELECTRONICS INC 203 11.1.13 KMC SYSTEMS 206 11.1.14 SAVYON DIAGNOSTICS 208 11.1.15 NOVA BIOMEDICAL 209 11.2 OTHER PLAYERS 211 11.2.1 CENOGENICS CORPORATION 211 11.2.2 CONE BIOPRODUCTS 211 11.2.3 AVIOQ, INC 212 11.2.4 PHILLIPS-MEDISIZE CORPORATION 213 11.2.5 INVETECH 214 11.2.6 MERIDIAN BIOSCIENCE, INC 214 11.2.7 NOLATO AB 216 11.2.8 FUJIREBIO 217 11.2.9 SEKISUI 218 11.2.10 PRESTIGE DIAGNOSTICS 218 11.2.11 BIOKIT 219 12 APPENDIX 220 12.1 DISCUSSION GUIDE 220 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 224 12.3 CUSTOMIZATION OPTIONS 226 12.4 RELATED REPORTS 226 12.5 AUTHOR DETAILS 227